TRIM63 and viral infectious disease: Our studies revealed the mechanisms underlying the impairment of antiviral type I IFN signaling and the role of upregulated MyD88 (MyD88–IRF interactions), which likely influence alternative MyD88-independent immune signaling pathways during many viral infections [25].